Financhill
Back

Grifols SA 10K Form

Sell
22

GRFS
Grifols SA

Last Price:
8.54
Seasonality Move:
4.09%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GRFS News And Ratings

See the #1 stock for the next 7 days that we like better than GRFS

GRFS Financial Statistics

Sales & Book Value

Annual Sales: $7.14B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $8.79
Price / Book: 1.05

Profitability

EPS (TTM): 0.31740
Net Income (TTM): $216.85M
Gross Margin: $2.7B
Return on Equity: 2.43%
Return on Assets: 0.93%

Grifols SA Earnings Forecast

Key Grifols SA Financial Ratios

  • The Gross Profit Margin over the past 19 years for GRFS is 37.84%.
  • The Selling, General & Administrative Expenses for GRFS have been equal to 19.11% of Gross Profit Margin.
  • The Research & Development expenses have been 6.00% of Revenue.
  • The Interest Expense is 870.03% of Operating Income.
  • The Net Earning history of GRFS is 0.90% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 11 years.

Grifols SA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: GRFS
CUSIP: 398438
Website: grifols.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.26
Quick Ratio: 0.77

Price-to-Earnings

Trailing P/E Ratio: 94.63
Forward P/E Ratio: 8.63

GRFS Technical Analysis vs Fundamental Analysis

Sell
22
Grifols SA (GRFS) is a Sell

Is Grifols SA a Buy or a Sell?

  • Grifols SA stock is rated a Sell
    The current Grifols SA [GRFS] share price is $8.60. The Score for GRFS is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.